Literature DB >> 22213267

Primary surgical treatment of T2 oropharyngeal carcinoma.

Georgios Psychogios1, Konstantinos Mantsopoulos, Julian Kuenzel, Michael Koch, Johannes Zenk, Uli Harreus, Frank Waldfahrer, Heinrich Iro.   

Abstract

BACKGROUND: The optimal management of oropharyngeal carcinoma (OPC) is not yet proven. The aim of this study is to analyze the outcome of primary surgical management of T2 cancers of the oropharynx.
METHODS: All patients treated with primary surgery for pT2 OPCs between 1984 and 2005 were evaluated retrospectively. Two hundred and twenty eight cases were assessed for disease-specific survival (DSS) as well as local control (LC) estimates, with respect to tumor location, surgical technique, status of surgical margins, N classification, and adjuvant therapy. Cases were also evaluated for major complications and functional results.
RESULTS: DSS was 73.2% and LC 88.9%. Carcinoma of the tonsils showed a significantly better DSS than lesions of the base of the tongue (DSS = 76.3 vs. 60.2%, P = 0.02). DSS estimates in patients with pN0-1 classification were significantly better in comparison with pN2-3 (83.6 vs. 64.5%, P = 0.018). Patients who were given adjuvant treatment had a better prognosis. The incidence of occult neck metastases was 17% and complications rate 12.7%.
CONCLUSIONS: Primary surgical treatment of T2 OPC proved to be an effective treatment modality with a low rate of complications and satisfactory functional results. Complete tumor excision is essential and a neck dissection is justified. Most patients need adjuvant radiotherapy.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22213267     DOI: 10.1002/jso.23026

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

1.  Lymph node ratio as a predictor of outcome in patients with oropharyngeal cancer.

Authors:  Julian Künzel; Georgios Psychogios; Konstantinos Mantsopoulos; Philipp Grundtner; Frank Waldfahrer; Heinrich Iro
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-06-19       Impact factor: 2.503

Review 2.  Occult lymph node metastasis in the contralateral neck of oropharyngeal squamous cell carcinoma: a meta-analysis and literature review.

Authors:  Ying Zhang; Xingzhou Su; Yumeng Qiao; Shaohui Huang; Yurong Kou
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-18       Impact factor: 2.503

3.  Early stage oropharyngeal carcinomas: comparing quality of life for different treatment modalities.

Authors:  Don-Felix Ryzek; Konstantinos Mantsopoulos; Julian Künzel; Philipp Grundtner; Johannes Zenk; Heinrich Iro; Georgios Psychogios
Journal:  Biomed Res Int       Date:  2014-02-25       Impact factor: 3.411

4.  Epidemiology and survival of HPV-related tonsillar carcinoma.

Authors:  Georgios Psychogios; Christoph Alexiou; Abba Agaimy; Kathrin Brunner; Michael Koch; Konstantinos Mantsopoulos; Andrea Tomppert; Heinrich Iro
Journal:  Cancer Med       Date:  2014-03-10       Impact factor: 4.452

5.  p16, Cyclin D1, and HIF-1α Predict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy.

Authors:  Asal S Rahimi; David D Wilson; Drew K Saylor; Edward B Stelow; Christopher Y Thomas; James F Reibel; Paul A Levine; David C Shonka; Mark J Jameson; Paul W Read
Journal:  Int J Otolaryngol       Date:  2012-07-24

6.  Outcome and prognostic factors in T4a oropharyngeal carcinoma, including the role of HPV infection.

Authors:  Georgios Psychogios; Konstantinos Mantsopoulos; Abbas Agaimy; Kathrin Brunner; Elisabeth Mangold; Johannes Zenk; Heinrich Iro
Journal:  Biomed Res Int       Date:  2014-03-31       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.